AR034166A1 - Procedimiento para la preparacion de polvos de inhalacion, y los polvos de inhalacion obtenibles con este procedimiento - Google Patents
Procedimiento para la preparacion de polvos de inhalacion, y los polvos de inhalacion obtenibles con este procedimientoInfo
- Publication number
- AR034166A1 AR034166A1 ARP010104784A ARP010104784A AR034166A1 AR 034166 A1 AR034166 A1 AR 034166A1 AR P010104784 A ARP010104784 A AR P010104784A AR P010104784 A ARP010104784 A AR P010104784A AR 034166 A1 AR034166 A1 AR 034166A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- inhalation powders
- preparation
- substance
- size
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
Abstract
Procedimiento para la preparación de polvos de inhalación, que se caracteriza porque N + m porciones de aproximadamente igual tamano de una sustancia con una distribución mayor del tamano de partículas (coadyuvante) y N porciones de igual tamano de una sustancia con una distribución menor del tamano de partículas (principio activo) se anaden de forma intermitente en capas a un recipiente de mezcla adecuado y, después de la adición completa, las 2N + m capas de los dos componentes se mezclan mediante un mezclador adecuado, efectuándose primeramente la adición de una porción de la sustancia con un tamano de partícula mayor, siendo N un número entero > 0, preferiblemente > 5 y representando m el número 0 ó 1. También se describen los polvos de inhalación obtenibles mediante este procedimiento de preparación que se destinan al tratamiento de una pluralidad de enfermedades, en particular, al tratamiento de enfermedades de las vías respiratorias. Estos polvos de inhalación se distinguen por un grado extraordinariamente elevado de homogeneidad en el sentido de una uniformidad en el contenido. Por consiguiente, el procedimiento descrito más arriba permite resolver los problemas de homogeneidad que presentan los procedimientos conocidos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10050635 | 2000-10-12 | ||
| DE2001138022 DE10138022A1 (de) | 2001-08-10 | 2001-08-10 | Verfahren zur Herstellung von Pulverformulierungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR034166A1 true AR034166A1 (es) | 2004-02-04 |
Family
ID=26007343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010104784A AR034166A1 (es) | 2000-10-12 | 2001-10-12 | Procedimiento para la preparacion de polvos de inhalacion, y los polvos de inhalacion obtenibles con este procedimiento |
Country Status (39)
| Country | Link |
|---|---|
| US (2) | US6585959B2 (es) |
| EP (1) | EP1326585B2 (es) |
| JP (2) | JP4986369B2 (es) |
| KR (1) | KR100849837B1 (es) |
| CN (1) | CN1269470C (es) |
| AR (1) | AR034166A1 (es) |
| AT (1) | ATE319422T1 (es) |
| AU (2) | AU1822002A (es) |
| BG (1) | BG66194B1 (es) |
| BR (1) | BR0114316A (es) |
| CA (1) | CA2425005C (es) |
| CY (1) | CY1105037T1 (es) |
| CZ (1) | CZ300022B6 (es) |
| DE (1) | DE50109178D1 (es) |
| DK (1) | DK1326585T4 (es) |
| EA (1) | EA004689B1 (es) |
| EE (1) | EE05146B1 (es) |
| EG (1) | EG24478A (es) |
| ES (1) | ES2259046T5 (es) |
| HR (1) | HRP20030277B1 (es) |
| HU (1) | HU229512B1 (es) |
| IL (2) | IL154919A0 (es) |
| ME (1) | ME02762B (es) |
| MX (1) | MXPA03003219A (es) |
| MY (1) | MY155912A (es) |
| NO (1) | NO333719B1 (es) |
| NZ (1) | NZ525781A (es) |
| PE (1) | PE20020424A1 (es) |
| PL (1) | PL204733B1 (es) |
| PT (1) | PT1326585E (es) |
| RS (1) | RS50495B (es) |
| SA (1) | SA01220518B1 (es) |
| SI (1) | SI1326585T2 (es) |
| SK (1) | SK285841B6 (es) |
| TW (1) | TWI283180B (es) |
| UA (1) | UA75375C2 (es) |
| UY (1) | UY26960A1 (es) |
| WO (1) | WO2002030390A2 (es) |
| ZA (1) | ZA200301349B (es) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK285389B6 (sk) * | 2000-10-12 | 2006-12-07 | Boehringer Ingelheim Pharma Kg | Inhalačný prášok s obsahom tiotrópia, kapsula s jeho obsahom a ich použitie |
| US6443152B1 (en) * | 2001-01-12 | 2002-09-03 | Becton Dickinson And Company | Medicament respiratory delivery device |
| CA2445650A1 (en) * | 2001-05-25 | 2002-12-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways |
| US20030070679A1 (en) * | 2001-06-01 | 2003-04-17 | Boehringer Ingelheim Pharma Kg | Capsules containing inhalable tiotropium |
| US20030008001A1 (en) * | 2001-06-13 | 2003-01-09 | Boehringer Ingelheim Pharma Kg | Process for cleaning hard gelatine capsules |
| US20030018019A1 (en) * | 2001-06-23 | 2003-01-23 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
| DE10141376A1 (de) * | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Inhalationspulvern |
| DE10141377A1 (de) | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Aufstreuverfahren zur Herstellung von Pulverformulierungen |
| US7309707B2 (en) * | 2002-03-20 | 2007-12-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
| US7244415B2 (en) * | 2002-03-28 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations of an anhydrate |
| MXPA04009583A (es) * | 2002-04-04 | 2005-01-11 | Boehringer Ingelheim Pharma | Nuevas formulaciones en polvo adecuadas para inhalacion. |
| GB0219511D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
| JP4744876B2 (ja) * | 2002-08-21 | 2011-08-10 | ノートン・ヘルスケアー リミテッド | 乾燥粉末吸入組成物の製造方法 |
| US20050158248A1 (en) * | 2002-08-21 | 2005-07-21 | Xian-Ming Zeng | Method of preparing dry powder inhalation compositions |
| AU2003269989B8 (en) * | 2002-08-21 | 2009-11-12 | Norton Healthcare Ltd. | Inhalation composition |
| GB0219513D0 (en) | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Inhalation compositions including coarse carrier |
| US7763280B2 (en) | 2002-11-28 | 2010-07-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing powder formulation for inhalation |
| DE10255387A1 (de) * | 2002-11-28 | 2004-06-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Tiotropium-haltige Pulverformulierung für die Inhalation |
| UA83813C2 (ru) * | 2002-12-20 | 2008-08-26 | Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг | Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола |
| DE10317461A1 (de) | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung |
| US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
| DE10331350A1 (de) * | 2003-07-11 | 2005-01-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum |
| US7462367B2 (en) | 2003-07-11 | 2008-12-09 | Boehringer Ingelheim International Gmbh | Anticholinergic powder formulations for inhalation |
| SI1699434T1 (sl) | 2003-09-02 | 2011-06-30 | Norton Healthcare Ltd | Postopek za pripravo zdravila |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| KR20060117334A (ko) | 2003-11-03 | 2006-11-16 | 베링거 인겔하임 인터내셔날 게엠베하 | 티오트로피움 염의 제조방법, 티오트로피움 염 및 이를함유하는 약제학적 조성물 |
| EP2083007B1 (de) | 2003-11-03 | 2013-04-24 | Boehringer Ingelheim International Gmbh | Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen |
| BRPI0417097A (pt) * | 2003-12-03 | 2007-03-13 | Microdrug Ag | inalador de pó seco de dose previamente medida para medicamentos sensìveis à umidade |
| DE102004048389A1 (de) | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa |
| ES2613391T3 (es) | 2005-02-10 | 2017-05-24 | Glaxo Group Limited | Procedimientos de fabricación de lactosa que utilizan técnicas de preclasificación y formulaciones farmacéuticas formadas a partir de la misma |
| GB0507835D0 (en) * | 2005-04-18 | 2005-05-25 | Solexa Ltd | Method and device for nucleic acid sequencing using a planar wave guide |
| DK1881980T3 (da) | 2005-05-02 | 2012-10-01 | Boehringer Ingelheim Int | Nye krystalline former af tiotropiumbromid |
| DE102005059602A1 (de) | 2005-12-14 | 2007-06-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Mikronisierung |
| ES2569359T3 (es) | 2007-07-06 | 2016-05-10 | Vectura Delivery Devices Limited | Inhalador |
| CN103691530A (zh) * | 2007-07-27 | 2014-04-02 | 卡吉尔公司 | 多元醇的微粉化 |
| EP2082772A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| EP2082771A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| EP2082767A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| EP2082766A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Blister Strip Coil Forming |
| EP2082768A1 (en) | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
| US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
| JP2011519699A (ja) | 2008-05-09 | 2011-07-14 | インノブアトイブエ プルモナルイ ソルウトイオンス，インコーポレイティッド | 気管支樹の治療のためのシステム、アセンブリ、及び方法 |
| WO2010010538A2 (en) * | 2008-07-24 | 2010-01-28 | L'air Liquide-Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | Heteroleptic cyclopentadienyl transition metal precursors for deposition of transition metal-containing films |
| TWI491416B (zh) * | 2008-12-24 | 2015-07-11 | Daiichi Sankyo Co Ltd | 吸入用乾燥粉末醫藥組成物 |
| GB0918450D0 (en) | 2009-10-21 | 2009-12-09 | Innovata Ltd | Composition |
| CA2779135C (en) | 2009-10-27 | 2018-09-04 | Innovative Pulmonary Solutions, Inc. | Delivery devices with coolable energy emitting assemblies |
| EP2842510B1 (en) | 2009-11-11 | 2022-08-24 | Nuvaira, Inc. | Device for treating tissue and controlling stenosis |
| US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
| US9259376B2 (en) | 2010-06-03 | 2016-02-16 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. | Process for dry powder formulations |
| TR201007251A2 (tr) * | 2010-09-01 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Kalsiyum kanal blokörü formülasyonu. |
| US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
| WO2016005443A1 (en) | 2014-07-09 | 2016-01-14 | Arven Ilac Sanayi Ve Ticaret A.S. | A process for the preparation of formulations for inhalation |
| PT3175842T (pt) * | 2015-12-03 | 2020-03-04 | Tiefenbacher Alfred E Gmbh & Co Kg | Processo de mistura de pó seco |
| WO2020013793A2 (en) * | 2018-07-12 | 2020-01-16 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Inhalation compositions comprising dopamine agonists |
| WO2022146255A1 (en) * | 2020-12-31 | 2022-07-07 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | A process for the preparation of dry powder compositions for inhalation |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1242211A (en) | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
| US3957965A (en) | 1967-08-08 | 1976-05-18 | Fisons Limited | Sodium chromoglycate inhalation medicament |
| US3860618A (en) | 1967-08-08 | 1975-01-14 | Philip Saxton Hartley | Chromone |
| BE891013A (fr) † | 1980-11-05 | 1982-05-05 | Fisons Ltd | Compositions pharmaceutique |
| JPS60150823A (ja) * | 1984-01-17 | 1985-08-08 | Satake Eng Co Ltd | 穀物混合装置 |
| JPH0439388A (ja) * | 1990-06-04 | 1992-02-10 | Teijin Ltd | 土砂と繊維状物との混合方法 |
| DE4140689B4 (de) * | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalationspulver und Verfahren zu ihrer Herstellung |
| JPH06198156A (ja) * | 1993-01-06 | 1994-07-19 | Nagasaki Pref Gov | 噴霧積層混合器 |
| IS1796B (is) * | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
| GB9322014D0 (en) * | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| GB9404945D0 (en) | 1994-03-15 | 1994-04-27 | Glaxo Group Ltd | Pharmaceutical composition |
| DE4425255A1 (de) * | 1994-07-16 | 1996-01-18 | Asta Medica Ag | Formulierung zur inhalativen Applikation |
| EP1131059B1 (de) * | 1998-11-13 | 2003-03-05 | Jago Research Ag | Trockenpulver zur inhalation |
| GB9902689D0 (en) | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
-
2001
- 2001-09-10 UA UA2003054184A patent/UA75375C2/uk unknown
- 2001-10-09 SK SK437-2003A patent/SK285841B6/sk not_active IP Right Cessation
- 2001-10-09 EA EA200300429A patent/EA004689B1/ru not_active IP Right Cessation
- 2001-10-09 NZ NZ525781A patent/NZ525781A/en not_active IP Right Cessation
- 2001-10-09 PL PL362511A patent/PL204733B1/pl unknown
- 2001-10-09 ME MEP-2008-427A patent/ME02762B/me unknown
- 2001-10-09 AU AU1822002A patent/AU1822002A/xx active Pending
- 2001-10-09 EP EP01986599A patent/EP1326585B2/de not_active Expired - Lifetime
- 2001-10-09 EE EEP200300170A patent/EE05146B1/xx unknown
- 2001-10-09 SI SI200130509T patent/SI1326585T2/sl unknown
- 2001-10-09 AU AU2002218220A patent/AU2002218220B2/en not_active Expired
- 2001-10-09 CN CNB01817146XA patent/CN1269470C/zh not_active Expired - Lifetime
- 2001-10-09 JP JP2002533833A patent/JP4986369B2/ja not_active Expired - Lifetime
- 2001-10-09 WO PCT/EP2001/011636 patent/WO2002030390A2/de not_active Ceased
- 2001-10-09 MX MXPA03003219A patent/MXPA03003219A/es active IP Right Grant
- 2001-10-09 HU HU0301268A patent/HU229512B1/hu unknown
- 2001-10-09 ES ES01986599T patent/ES2259046T5/es not_active Expired - Lifetime
- 2001-10-09 BR BR0114316-6A patent/BR0114316A/pt not_active Application Discontinuation
- 2001-10-09 IL IL15491901A patent/IL154919A0/xx active IP Right Grant
- 2001-10-09 KR KR1020037005039A patent/KR100849837B1/ko not_active Expired - Lifetime
- 2001-10-09 PT PT01986599T patent/PT1326585E/pt unknown
- 2001-10-09 HR HR20030277A patent/HRP20030277B1/xx not_active IP Right Cessation
- 2001-10-09 RS YUP-274/03A patent/RS50495B/sr unknown
- 2001-10-09 CZ CZ20031024A patent/CZ300022B6/cs not_active IP Right Cessation
- 2001-10-09 AT AT01986599T patent/ATE319422T1/de active
- 2001-10-09 CA CA 2425005 patent/CA2425005C/en not_active Expired - Lifetime
- 2001-10-09 DK DK01986599.7T patent/DK1326585T4/da active
- 2001-10-09 TW TW090124981A patent/TWI283180B/zh not_active IP Right Cessation
- 2001-10-09 DE DE50109178T patent/DE50109178D1/de not_active Expired - Lifetime
- 2001-10-10 PE PE2001001002A patent/PE20020424A1/es active IP Right Grant
- 2001-10-10 MY MYPI20014704A patent/MY155912A/en unknown
- 2001-10-10 EG EG2001101063A patent/EG24478A/xx active
- 2001-10-10 UY UY26960A patent/UY26960A1/es not_active IP Right Cessation
- 2001-10-11 US US09/977,911 patent/US6585959B2/en not_active Ceased
- 2001-10-12 AR ARP010104784A patent/AR034166A1/es unknown
- 2001-11-11 SA SA01220518A patent/SA01220518B1/ar unknown
-
2003
- 2003-02-19 ZA ZA2003/01349A patent/ZA200301349B/en unknown
- 2003-03-13 IL IL154919A patent/IL154919A/en unknown
- 2003-03-26 BG BG107673A patent/BG66194B1/bg unknown
- 2003-04-11 NO NO20031692A patent/NO333719B1/no not_active IP Right Cessation
-
2004
- 2004-01-28 US US10/766,748 patent/USRE38912E1/en not_active Expired - Lifetime
-
2006
- 2006-05-19 CY CY20061100654T patent/CY1105037T1/el unknown
-
2009
- 2009-06-08 JP JP2009136927A patent/JP2009197025A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR034166A1 (es) | Procedimiento para la preparacion de polvos de inhalacion, y los polvos de inhalacion obtenibles con este procedimiento | |
| MEP90608A (bs) | Postupak za spravljanje smješa | |
| BR0110139A (pt) | Formulações farmacêuticas para inaladores de pó seco | |
| AR011080A1 (es) | Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento | |
| BR0108730A (pt) | Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados | |
| DE60133555D1 (de) | Verbindungen und gemische zur verabreichung eines aktiven agens | |
| ES2126536A1 (es) | "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion. | |
| CN1226924A (zh) | 具有抗病毒和杀精子活性的含有壬苯聚醇的脂囊泡 | |
| ATE387430T1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
| ATE271383T1 (de) | Pulverformulierung zur inhalation | |
| IL153011A0 (en) | Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds | |
| ATE495748T1 (de) | Parasiticide formulierung und methode zur herstellung dieser formulierung | |
| TW200503782A (en) | New formulations and use thereof | |
| AR039317A1 (es) | Proceso para la preparacion de una suspension esteril de particulas de dipropionato de beclometasona para administracion por inhalacion | |
| BR0212857A (pt) | Formulações e uso destas | |
| JP2026042058A (ja) | 組成物およびその用途 | |
| BG107257A (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
| CO4520283A1 (es) | Agentes antivirales | |
| PL368686A1 (en) | Novel aminobenzoephenones | |
| CN113116897B (zh) | 木兰花碱在制备骨调节药物增效剂中的应用及包含木兰花碱的药物组合物 | |
| US20170216169A1 (en) | Artificial Saliva | |
| RU94044114A (ru) | Лекарственный порошкообразный препарат для ингаляций | |
| BR0212834A (pt) | Formulações e uso das mesmas | |
| AR060039A1 (es) | Formulaciones novedosas | |
| Uzuner et al. | Investigation of long-term effect of Black Sea bee’s venom on the cytotoxicity of pancreatic cancer cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |